Stock analysis, AI verdict, fundamentals & technical signals
Rating: BUY
Price: $39.70 Analyst target: $58.00 Upside: 46.10%
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. The company is headquartered in New York, New York.
See the full interactive analysis & chart →Informational only — not investment advice.